February, 09 2022, 05:29pm EDT
Sanders Asks for Unanimous Consent on Legislation to Lower the Cost of Prescription Drugs
Senators Sanders and Klobuchar introduced legislation today to empower Medicare to pay the same prices for prescription drugs as the Veterans Administration.
WASHINGTON
Sen. Bernie Sanders (I-Vt.) today will deliver remarks on the floor of the U.S. Senate asking for unanimous consent for debate to begin on legislation to lower the cost of prescription drugs for millions of Americans. This legislation, introduced today by Sens. Sanders and Amy Klobuchar (D-Minn.), empowers Medicare to pay lower prices for prescription drugs, like the Veterans Administration.
Sanders' remarks, as prepared for delivery, are below:
"Mr. President: Let's be clear. There is significant discontent in our country today. The American people are worried about COVID, but they're worried about much more. They're worried about inflation - the price of food and gas and other products.
"They're worried about climate change and the kind of planet they'll be leaving their kids and future generations.
"They're worried about a middle class whose real inflation accounted for wages have not risen in almost 50 years and the reality that half of our workforce lives paycheck to paycheck.
"They're worried about the massive level of income and wealth inequality that we are experiencing in which, during this pandemic alone, the billionaire class saw an increase in their wealth by some $2 trillion while thousands of workers died doing their jobs.
"They're worried that their kids are not getting quality childcare or a decent education or that they're unable to pay the outrageous levels of student debt that they acquired because they chose to go to college.
"And, Mr. President, maybe above all else, the American people are outraged that in the midst of all of the crises that we face their elected officials are not responding.
"In my view, now is the time to tell the American people that Congress understands their pain and that we are prepared to fight for working people against the greed of the powerful special interests who wield so much power over the economic and political life of the nation.
"And today, Senator Klobuchar and I are going to focus on one of the many issues that must be addressed by Congress.
"Mr. President: For decades, decades, members of both political parties have come to the floor of the Senate and the House, bemoaning the high cost of prescription drugs in this country and promising the American people that they would lower those outrageous prices. They have given speech after speech and spent millions on 30 second campaign ads telling their constituents all that they were going to do to take on the pharmaceutical industry.
"And for decades they have failed to deliver.
"They have failed to deliver under Democratic leadership and they have failed to deliver under Republican leadership.
"They have failed to deliver because of the greed of the pharmaceutical industry - which today may well be the most powerful corporate interest in America and is certainly the dominant political force here in Washington, DC.
"My fellow Americans: Do you want to know why you're paying the highest prices in the world for prescription drugs, sometimes 10 times more for the same exact drug that is sold in Canada and other countries?
"Do you want to know why 1 out of 4 Americans are unable to afford the prescription drugs their doctors prescribe?
"Do you want to know why thousands of Americans die every year because they can't afford their medicine?
"Do you know why millions of diabetic Americans actually ration their insulin?
"I will tell you why. During the past 20 years, the pharmaceutical industry has spent over $4.5 billion on lobbying and hundreds of millions of dollars in campaign contributions.
"These are campaign contributions which go to Republicans. These are campaign contributions that go to Democrats. And I'm talking about hundreds of members of the House and Senate.
"Further, the pharmaceutical industry has, over the years, mounted an unprecedented lobbying effort in Washington and in states all over this country.
"I want you to hear this. Last year alone, the pharmaceutical industry hired more than 1,700 well-paid lobbyists to Capitol Hill to protect their interests --including the former congressional leaders of both major political parties. Got that? That's over 3 pharmaceutical industry lobbyists for every Member of Congress.
"And what is the result of all that lobbying and all those campaign contributions? The answer is clear. The pharmaceutical industry in America, uniquely in the entire world, is able to raise prices to any level that they want any time that they want.
"Tomorrow, if you walk into your pharmacy the price of the medicine you take could be much higher than it was yesterday. And the reason? Nothing more complicated than the drug companies simply wanting to make more money.
"And boy is that working. Eight of the largest drug companies in the United States made nearly $50 billion in profits in 2020, while the CEOs in those pharmaceutical giants took home over $350 million in total compensation.
"Let me repeat that. The 8 largest drug companies in the U.S. made nearly $50 billion in profits while paying their CEOs over $350 million in compensation in 2020.
"Let's be very clear. The overriding motivation of the pharmaceutical industry is greed. Their overriding goal is to make as much money as they can by squeezing as much as they possibly can out of the sick, out of the elderly and out of the desperate.
"Let me give you just a few examples of the greed within the pharmaceutical industry.
"Just a few years ago, the former CEO of Gilead became a billionaire by charging a thousand dollars for the hepatitis C drug Sovaldi. As is often the case, the drug was developed by taxpayer dollars at the VA. The drug costs just $1 to manufacture and can be purchased in India for all of $4.
"In 2016, the chairman of Mylan, received a $164 million compensation package after his company jacked-up the price of an EpiPen by 550 percent over a nine-year period.
"Mr. President: All over this country, the American people are asking a simple question: How many people need to die, how many people need to get unnecessarily sicker before Congress is prepared to take on the greed of the prescription drug industry?
"Enough is enough. A life-saving prescription drug does not mean anything if you cannot afford to buy that drug.
"We cannot allow the pharmaceutical industry to charge the American people, by far, the highest prices in the world for prescription drugs.
"That is why I have introduced legislation today with Senator Klobuchar that would cut the price of prescription drugs under Medicare in half.
"And it would do that by making sure that Medicare pays the same low prices for prescription drugs as the VA does.
"Mr. President: Why is it that the VA pays so much less for prescription drugs than Medicare? The answer is simple.
"While the VA has been able to negotiate with the pharmaceutical industry for the past 30 years, Congress banned Medicare by law from doing anything to lower prescription drug prices.
"And the result is that, according to the non-partisan Government Accountability Office, Medicare pays twice as much for the same exact prescription drugs as the VA.
"Let me repeat that. Medicare, which is banned by law from negotiating with the pharmaceutical industry, pays twice as much for the same exact prescription drugs as the VA, which has been negotiating for lower prices for the past 30 years.
"That is totally absurd.
"If the VA can negotiate with the pharmaceutical companies to substantially reduce the price of prescription drugs, you know what? We can require Medicare to receive the same exact prices that the VA pays for prescription drugs. And when we do that, we could save Medicare some $900 billion over the next decade.
"And, Mr. President, the VA is not the only agency that negotiates for lower drug prices. This is something that every other major country on the planet does.
"Mr. President: As you may know, on two occasions, I have taken Americans over the border to Canada to purchase prescription drugs. In one case, it was the breast cancer drug tamoxifen. In the other case, it was the insulin needed by diabetics.
"In both cases, they were able to purchase these desperately needed prescription drugs for one-tenth of the price that they were paying in the United States. I will never forget the tears that were shed when these people, fighting life threatening illnesses were able to buy their medicine for a tiny fraction of the price that they were paying in the U.S.
"There is no rational reason, other than greed, for the pharmaceutical industry to charge the American people $98.70 for a standard unit of insulin that can be purchased in the United Kingdom for just $7.52.
"There is no rational reason, other than greed, for the pharmaceutical industry to charge the American people $242 for the asthma inhaler - Flovent Diskus - that can be purchased for just $27 in Canada.
"There is no rational reason, other than greed, for the pharmaceutical industry to charge the American people $686 for 2 EpiPens that can be purchased in Australia for just $169.
"And let's be clear. These are the same medications, manufactured by the same companies, in the same factories - that are all available in Canada, in Europe, in Australia and in Japan for a fraction of the price.
"For far too long, it has not been Congress that has been regulating the pharmaceutical industry. It has been the pharmaceutical industry that has been regulating Congress.
"Well, those days will be coming to an end if Members of Congress finally have the courage to stand up to the power of the pharmaceutical industry.
"And that is exactly what the American people want us to do.
"According to an October 2021 poll by the Kaiser Family Foundation, 83% of the American people want Medicare to negotiate with the pharmaceutical industry to lower the price of prescription drugs.
"According to a July 2021 poll by Gallup, 81% of the American people believe that Medicare should be empowered to negotiate for lower prescription drug prices and 77% of the American people believe that the federal government should limit price hikes on all prescription drugs.
"Mr. President. The time for talk is over. The time to act is now. It's time for the Senate to have a debate and a vote to bring down the outrageous price of prescription drugs.
"So, Mr. President, as if in Legislative Session, I ask unanimous consent that at a time to be determined today by the Majority Leader, following consultation with the Republican Leader, the Senate proceed to the consideration of S.3615, which was introduced earlier today, that there be 2 hours for debate equally divided, that upon the use or yielding back of time, the bill be read a third time, and the Senate vote on passage of the bill, without intervening action or debate."
LATEST NEWS
Once Again, Tom Cotton Blocks Bill to Shield Journalists From Betraying Sources
Responding to the GOP senator's latest thwarting of the PRESS Act, Democratic Sen. Ron Wyden vowed to "keep trying to get this bill across the finish line" before Republicans take control of the Senate next month.
Dec 10, 2024
Republican U.S. Sen. Tom Cotton of Arkansas on Tuesday again blocked the passage of House-approved bipartisan legislation meant to shield journalists and telecommunications companies from being compelled to disclose sources and other information to federal authorities.
Sen. Ron Wyden (D-Ore.) brought the Protect Reporters from Exploitative State Spying (PRESS) Act—which would prohibit the federal government from forcing journalists and telecom companies to disclose certain information, with exceptions for terroristic or violent threats—for a unanimous consent vote.
Senate Majority Leader Chuck Schumer (D-N.Y.) argued Tuesday that passing the PRESS Act is "more important now than ever before when we've heard some in the previous administration talk about going after the press in one way or another," a reference to Republican President-elect Donald Trump's threats to jail journalists who refuse to reveal the sources of leaks. Trump, who has referred to the press as the "enemy of the people," repeatedly urged Senate Republicans to "kill this bill."
Cotton, who blocked a vote on the legislation in December 2022, again objected to the bill, a move that thwarted its speedy passage. The Republican called the legislation a "threat to national security" and "the biggest giveaway to the liberal press in American history."
The advocacy group Defending Rights and Dissent lamented that "Congress has abdicated their responsibility to take substantive steps to protect the constitutional right to a free press."
However, Seth Stern, director of advocacy at the Freedom of the Press Foundation, noted ways in which Senate Democrats can still pass the PRESS Act before Republicans gain control of the upper chamber next month:
Senate Democrats had all year to move this bipartisan bill and now time is running out. Leader Schumer needs to get the PRESS Act into law—whether by attaching it to a year-end legislative package or bringing it to the floor on its own—even if it means shortening lawmakers' holiday break. Hopefully, today was a preview of more meaningful action to come.
Responding to Tuesday's setback, Wyden vowed, "I'm not taking my foot off the gas."
"I'll keep trying to get this bill across the finish line to write much-needed protections for journalists and their sources into black letter law," he added.
Keep ReadingShow Less
Judges Block Kroger-Albertsons Merger in 'Win for Farmers, Workers, and Consumers'
"We applaud the FTC for securing one of the most significant victories in modern antitrust enforcement," said one advocate.
Dec 10, 2024
Antitrust advocates on Tuesday welcomed a pair of court rulings against the proposed merger of grocery giants Kroger and Albertsons, which was challenged by Federal Trade Commission Chair Lina Khan and multiple state attorneys general.
"The FTC, along with our state partners, scored a major victory for the American people, successfully blocking Kroger's acquisition of Albertsons," said Henry Liu, director of the commission's Bureau of Competition, in a statement. "This historic win protects millions of Americans across the country from higher prices for essential groceries—from milk, to bread, to eggs—ultimately allowing consumers to keep more money in their pockets."
"This victory has a direct, tangible impact on the lives of millions of Americans who shop at Kroger or Albertsons-owned grocery stores for their everyday needs, whether that's a Fry's in Arizona, a Vons in Southern California, or a Jewel-Osco in Illinois," he added. "This is also a victory for thousands of hardworking union employees, protecting their hard-earned paychecks by ensuring Kroger and Albertsons continue to compete for workers through higher wages, better benefits, and improved working conditions."
While Liu was celebrating the preliminary injunction from Oregon-based U.S. District Court Judge Adrienne Nelson, later Tuesday, King County Superior Court Judge Marshall Ferguson released a ruling that blocked the merger in Washington state.
"We're standing up to mega-monopolies to keep prices down," said Washington Attorney General Bob Ferguson. "We went to court to block this illegal merger to protect Washingtonians' struggling with high grocery prices and the workers whose jobs were at stake. This is an important victory for affordability, worker protections, and the rule of law."
Advocacy groups applauding the decisions also pointed to the high cost of groceries and the anticipated impact of Kroger buying Albertsons—a $24.6 billion deal first announced in October 2022.
"American families are the big winner today, thanks to the Federal Trade Commission. The only people who stood to gain from the potential merger between Albertsons and Kroger were their wealthy executives and investors," asserted Liz Zelnick of Accountable.US. "The rest of us are letting out a huge sigh of relief knowing today's victory is good news for competitive prices and consumer access."
Describing the federal decision as "a victory for commonsense antitrust enforcement that puts people ahead of corporations," Food & Water Watch senior food policy analyst Rebecca Wolf also pointed out that "persistently high food prices are hitting Americans hard, and a Kroger-Albertsons mega-merger would have only made it worse."
"Already, a handful of huge corporations' stranglehold on our food system means that consumers are paying too much for too little choice in supermarkets, workers are earning too little, and farmers and ranchers cannot get fair prices for their crops and livestock," she noted. "Today's decision and strengthened FTC merger guidelines help change the calculus."
Like Wolf, Farm Action president and co-founder Angela Huffman similarly highlighted that "while industry consolidation increases prices for consumers and harms workers, grocery mergers also have a devastating impact on farmers and ranchers."
"When grocery stores consolidate, farmers have even fewer options for where to sell their products, and the chances of them receiving a fair price for their goods are diminished further," Huffman explained. "Today's ruling is a win for farmers, workers, and consumers alike."
Some advocates specifically praised Khan—a progressive FTC chair whom President-elect Donald Trumpplans to replace with Andrew Ferguson, a current commissioner who previously worked as chief counsel to Senate Minority Leader Mitch McConnell (R-Ky.) and as Republican counsel on the Senate Judiciary Committee.
"Today's decision is a major win for shoppers and grocery workers. Families have been paying the price of unchecked corporate power in the food and grocery sector, and further consolidation would only worsen this crisis," declared Groundwork Collaborative executive director Lindsay Owens in a statement.
"FTC Chair Lina Khan's approach is the blueprint to deliver lower prices, higher wages, and an economy that works for everyone," Owens argued. "The rebirth of antitrust enforcement has protected consumers against the worst of corporate power in our economy and it would be wise to continue this approach."
Laurel Kilgour, research manager at the American Economic Liberties Project, called the federal ruling "a resounding victory for workers, consumers, independent retailers, and local communities nationwide—and a powerful validation of Chair Khan and the FTC's rigorous enforcement of the law."
"The FTC presented a strong case that Kroger and Albertsons fiercely compete head-to-head on price, quality, and service. The ruling is a capstone on the FTC's work over the past four years and includes favorable citations to the FTC's recent victories against the Tapestry-Capri, IQVIA-Propel, and Illumina-Grail mergers," Kilgour continued.
"The court also cites long-standing Supreme Court law which recognizes that Congress was also concerned with the impacts of mergers on smaller competitors," she added. "We applaud the FTC for securing one of the most significant victories in modern antitrust enforcement and for successfully protecting the public interest from harmful consolidation."
Despite the celebrations, the legal battle isn't necessarily over.
The Associated Pressreported that "the case may now move to the FTC, although Kroger and Albertsons have asked a different federal judge to block the in-house proceedings," and Colorado is also trying to halt the merger in state court.
Keep ReadingShow Less
Trump Taps Anti-Trans Lawyer Harmeet Dhillon for Key Civil Rights Post
"Dhillon has focused her career on diminishing civil rights, rather than enforcing or protecting them," argued one critic.
Dec 10, 2024
LGBTQ+ and voting rights defenders were among those who sounded the alarm Tuesday over Republican President-elect Donald Trump's selection of a San Francisco attorney known for fighting against transgender rights and for leading a right-wing lawyers' group that took part in Trump's effort to overturn the 2020 presidential election to oversee the U.S. Department of Justice Civil Rights Division.
On Monday, Trump announced his nomination of Harmeet Dhillon to head the key civil rights office, claiming on his Truth Social network that the former California Republican Party vice-chair "has stood up consistently to protect our cherished Civil Liberties, including taking on Big Tech for censoring our Free Speech, representing Christians who were prevented from praying together during COVID, and suing corporations who use woke policies to discriminate against their workers."
"In her new role at the DOJ, Harmeet will be a tireless defender of our Constitutional Rights, and will enforce our Civil Rights and Election Laws FAIRLY and FIRMLY," Trump added.
However, prominent trans activist Erin Reed warned on her Substack that Dhillon's nomination—which requires Senate confirmation—"signals an alarming shift that could make life increasingly difficult for transgender people nationwide, including those who have sought refuge in blue states to escape anti-trans legislation."
Trump has picked Harmeet Dhillon as Assistant Attorney General for Civil Rights. She has stated that it must be "made unsafe" for hospitals to provide trans care, and frequently shares Libs of TikTok posts. She intends to target trans people in blue states. Subscribe to support my journalism.
[image or embed]
— Erin Reed (@erininthemorning.com) December 10, 2024 at 8:14 AM
Reed continued:
Dhillon's most prominent work includes founding the Center for American Liberty, a legal organization that focuses heavily on anti-transgender cases in blue states. The organization's "featured cases" section highlights several lawsuits, such as Chloe Cole's case against Kaiser Permanente; a lawsuit challenging a Colorado school's use of a transgender student's preferred name; a case against a California school district seeking to implement policies that would forcibly out transgender students; and a lawsuit against Vermont for denying a foster care license to a family unwilling to comply with nondiscrimination policies regarding transgender youth.
Reed also highlighted Dhillon's attacks on state laws protecting transgender people, as well as her expression of "extreme anti-trans views" on social media—including calling gender-affirming healthcare for trans children "child abuse."
Last year, The Guardian's Jason Wilson reported that the Center for American Liberty made a six-figure payment to a public relations firm that represented Dhillion in both "her capacity as head of her own for-profit law firm and Republican activist."
Writing for the voting rights platform Democracy Docket, Matt Cohen on Tuesday accused Dhillon of being "one of the leading legal figures working to roll back voting rights across the country."
"In the past few years, Dhillon—or an attorney from her law firm—has been involved in more than a dozen different lawsuits in Arizona, Colorado, Georgia, Maine, Michigan, North Carolina, Virginia, and Washington, D.C. challenging voting rights laws, redistricting, election processes, or Trump's efforts to appear on the ballot in the 2024 election," Cohen noted.
As Maya Wiley, president and CEO of the Leadership Conference on Civil and Human Rights, said in a statement Tuesday, "The Department of Justice's Civil Rights Division has the critical responsibility of enforcing our nation's federal civil rights laws and ensuring equal justice under the law on behalf of all of our communities."
"That means investigating police departments that have a pattern of police abuse, protecting the right to vote, and ensuring schools don't discriminate against children based on who they are," Wiley noted. "The nomination of Harmeet Dhillon to lead this critical civil rights office is yet another clear sign that this administration seeks to advance ideological viewpoints over the rights and protections that protect every person in this country."
"Dhillon has focused her career on diminishing civil rights, rather than enforcing or protecting them," she asserted. "Rather than fighting to expand voting access, she has worked to restrict it."
A staunch Trump loyalist, Dhillon has also embraced conspiracy theories including the former president's "Big Lie" that the 2020 presidential election was stolen, and has accused Democrats of "conspiring to commit the biggest election interference fraud in world history."
She was co-chair of the Republican National Lawyers Association when it launched Lawyers for Trump, a group that urged the U.S. Supreme Court to intervene on behalf of the former president after he lost the 2020 election.
Cohen also highlighted Dhillon's ties to right-wing legal activist and Federalist Society co-chair Leonard Leo, described by Sen. Sheldon Whitehouse (D-R.I.) as a "lawless con man and crook" for his refusal to comply with a Senate subpoena and his organization of lavish gifts to conservative U.S. Supreme Court justices.
"We need a leader at the Civil Rights Division who understands that civil rights protections are not partisan or political positions open to the ideological whims of those who seek to elevate a single religion or to protect political allies or particular groups over others," Wiley stressed. "We need a leader who will vigorously enforce our civil rights laws and work to protect the rights of all of our communities—including in voting, education, employment, housing, and public accommodations—without fear or favor."
Keep ReadingShow Less
Most Popular